Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Device Sector’s Growth, Economic Contribution Need Government Support, Report Suggests

This article was originally published in The Gray Sheet

Executive Summary

AdvaMed renews call for device-industry-friendly policies, including repeal of the device tax set to start next year, in promoting a report on the economic impact of the U.S. device industry.

You may also be interested in...

Device Tax Repeal As Tax Reform: AdvaMed Makes The Case

AdvaMed aims to “decouple” discussion of the device tax from the health care reform debate and link its repeal to broader efforts focused on improving the U.S. tax system.

Industry Asks Washington To Protect U.S. Leadership In MedTech Innovation

Nonprofit and trade groups representing the medical device, diagnostics and pharmaceutical industries are calling for a bipartisan push from Congress and the Obama administration to protect the U.S. leadership role in biomedical innovation.

AdvaMed Steps Up Effort To Link Device Tax Repeal To Job Growth

Device lobbyists are hoping to take advantage of renewed emphasis among federal policymakers on creating jobs to push through a repeal of the medical device excise tax, scheduled to take effect in 2013.

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts